US Patent Issued to Psilobrain Therapeutics on Oct. 20 for "Compositions and methods for anxiety disorder treatment" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,128, issued on Oct. 20, was assigned to Psilobrain Therapeutics Inc. (Surrey, Canada).

"Compositions and methods for anxiety disorder treatment" was invented by Fadia Saad (Victoria, Canada), Rose Perry (Brooklyn, N.Y.) and Kevin Coft (Langley, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in treatment of anxiety disorder. Further provided herein are me...